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The S segment of Rift Valley fever virus (Bunyaviridae, Phlebovirus) codes for two proteins, the nucleoprotein N and the
nonstructural protein NSs. The NSs protein is a phosphoprotein of unknown function that is localized in the cytoplasm and
the nuclei of infected cells where it forms filamentous structures. To characterize further the protein expressed in VC10 cells
infected with the MP12 strain, we analyzed its phosphorylation states and showed that phosphorylated forms were found in
both compartments. Cytoplasmic and nuclear NSs were phosphorylated only at serine residues. Phosphopeptide mapping
and molecular analysis of mutants obtained by site-directed mutagenesis allowed us to map the major phosphorylation sites
of nuclear and cytoplasmic forms of NSs to serine residues 252 and 256, located at the carboxy-terminus in consensus
sequences for casein kinase II. A similar map was obtained when the protein was purified from mosquito cells infected with
MP12. In addition, we showed that the purified unphosphorylated NSs protein expressed from pET-NSs plasmid in a coupled
transcription–translation reaction containing Escherichia coli S30 extracts did not possess autophosphorylation activity but
was phosphorylated in vitro after incubation with recombinant casein kinase II. © 1999 Academic Press
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DINTRODUCTION
Rift Valley fever virus (RVFV) was isolated for the first
ime in Kenya in 1931 during a large epizootic. Since
hen, human infections have been described, and RVFV
urned out to be a public health problem in Africa. RVFV
s a mosquito-borne virus that reemerged recently in
990–91 in Madagascar (Morrill and McClain, 1996), in
993 in Egypt, in 1997–98 in Kenya, Somalia, and Tanza-
ia (Sall et al., 1998), and in 1998 in Mauritania (A. Sall,
ersonal communication). Epidemics often were associ-
ted with floods, dam implementation or ecological
hanges that led to vector amplification. Various symp-
oms were observed during human infection, ranging
rom benign fever, retinitis, or encephalitis to fatal hem-
rragic fever associated with hepatitis.
RVFV belongs to the Bunyaviridae family (genus Phle-
ovirus), a family of spherical enveloped viruses with a
risegmented, single-stranded RNA genome of negative
r ambisense polarity (Murphy et al., 1995). The L and M
egments are of negative polarity and code respectively
or the L protein (an RNA-dependent RNA polymerase)
nd for the precursor to the envelope glycoproteins G1
nd G2, whereas the S segment utilizes an ambisense
trategy and codes for two proteins, the nucleoprotein N
nd the nonstructural protein NSs (for reviews, see El-
iott, 1996; Schmaljohn, 1996). The NSs proteins of differ-
1 To whom reprint requests should be addressed. Fax: (01) 40613151.
N-mail: mbouloy@pasteur.fr.
517nt Phleboviruses are poorly conserved in their primary
equence (Giorgi et al., 1991). Their functions are un-
nown and their biological properties were shown to
iffer from one phlebovirus to the other (Yadani et al.,
999 and references cited).
Among members of the Bunyaviridae, RVFV is unique
s its NSs protein is phosphorylated and found in the
ucleus of infected cells where it forms filamentous
tructures (Struthers and Swanepoel, 1982; Parker et al.,
984; Struthers et al., 1984). The presence of a non
tructural protein in the nucleus is surprising, since
VFV, like all the other members of the family, replicates
n the cytoplasm. To determine whether NSs has a role in
he RVFV life cycle, Lopez et al. (1995) and Pre´haud et al.
1997) tested a putative function in transcription-replica-
ion by using a transcription reconstitution system, but
he protein was found to have neither a stimulatory nor
n inhibitory effect on transcription. Recent experiments
howed that NSs interacts with itself to form multimers
Yadani et al., 1999) and with viral and cellular structures
F. Yadani et al., manuscript in preparation). These inter-
ctions might be key functions to understand the role of
he NSs protein.
Phosphorylation is known to regulate several protein–
rotein interactions (Fuchs et al., 1998). RNA viruses
ossess many structural and nonstructural proteins that
re phosphorylated. Phosphorylation of the P protein of
habdoviruses and paramyxoviruses (for a review, see
e and Banerjee, 1997) or the influenza A virus proteins,
P, NS1, NS2, M1, PA, and M2, (Thomas et al., 1998) is
0042-6822/99 $30.00
Copyright © 1999 by Academic Press
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518 KOHL, DI BARTOLO, AND BOULOYell documented. In the case of the P protein of vesicular
tomatitis virus (VSV), phosphorylation/dephosphoryla-
ion would regulate transcription and replication of the
enome (Gupta and Banerjee, 1997; Hwang et al., 1999).
he degree of phosphorylation may affect also the intra-
ellular localization of the protein: in rotavirus-infected
ells, complete phosphorylation of the nonstructural pro-
ein NSP5 must be achieved for the protein to reach its
ntracellular localization (Poncet et al., 1997). Similarly,
hosphorylation of the NS5 protein of type 2 Dengue
irus correlates with its subcellular localization and as-
ociation with NS3 (Kapoor et al., 1995).
Because the biological properties of RVFV NSs protein
ight be affected by phosphorylation, we undertook a
iochemical analysis to determine its phosphorylation
tates. In this study, we showed that the major phosphor-
lation sites of NSs are the serine residues located in the
cidic carboxy-terminus at positions 252 and 256. In vitro
ata strongly suggest that NSs does not possess any
utocatalytic activity for phosphorylation but that casein
inase II (CKII) most probably is responsible for phos-
horylation of these two serine residues.
RESULTS
phosphorylated form of NSs is detected in the
ytoplasm and nucleus of VC10 cells infected
ith RVFV MP12 strain
Recently, Yadani et al. (1999) showed that the NSs
rotein was present both in the cytoplasm and nuclei of
VFV-MP12-infected VC10 cells. To address the question
f the phosphorylation of the protein in these compart-
ents, VC10 cells were infected with the MP12 strain
nd labeled with [32P]orthophosphate or [35S]methionine/
ysteine for 2 h from 6 to 8 h p.i. Nuclear and cytoplasmic
ractions were isolated, the NSs protein was immunopre-
ipitated using anti-NSs antibodies and analyzed in a
0% SDS–polyacrylamide gel. NSs protein labeled with
32P]orthophosphate or [35S]methionine/cysteine was de-
ected in the cytoplasmic and nuclear extracts of infected
ells (Fig. 1A). The distribution of the NSs protein in the
wo compartments after labeling with [35S]methionine/
ysteine or with [32P]orthophosphate was not signifi-
antly different.
Because phosphate groups are known to reduce the
lectrophoretic mobility of the proteins in SDS–poly-
crylamide gels, we wanted to know whether several
orms of the protein coexist in these compartments. To
istinguish unphosphorylated and phosphorylated forms
f NSs, extracts of cells infected with MP12 and labeled
ith [35S]methionine/cysteine were treated with alkaline
hosphatase, the NSs protein was immunoprecipitated
nd electrophoresed in Tris–Tricine polyacrylamide gels.
nder these conditions, the dephosphorylated form mi-
rated slightly faster than the cytoplasmic and nuclearorms of untreated NSs, which appeared as single and sharp bands (Fig. 1B). This suggests that the major form
ccumulating in both compartments is phosphorylated
nd that phosphorylation of the newly translated protein
ccurs rapidly.
utational analysis of the NSs protein
The NSs protein of the MP12 strain is composed of
65 amino acids (molecular mass 29,900) and contains
hree potential phosphorylation sites for protein kinase C
PKC) at serines 13, 127, and 148 and three for casein
inase II (CKII) at threonine 97, serine 252, and 256, the
wo latter ones being located in the sequence ..SEEES-
DD.. at the highly acidic carboxy-terminus (Fig. 2A).
hese consensus sites are highly conserved among
VFV strains of different origins (Sall et al., 1997). Expres-
ion of the NSs protein of MP12 and several deletion
utants (Yadani et al., 1999) indicated that the 17 car-
oxy-terminal amino acids that include serine residues
52 and 256 are responsible for interaction of NSs with
tself. To determine the sites of phosphorylation utilized
n the NSs protein of MP12, we performed a preliminary
xperiment in which the NSs-CD17 mutant (Fig. 2A) was
ransiently expressed in recombinant vTF7–3 vaccinia-
irus-infected CV1 cells transfected with plasmid pGem
Ss-CD17. Analysis was carried out after labeling these
ells in the presence of [32P]orthophosphate or a mixture
f [35S]methionine and [35S]cysteine. The protein was
mmunoprecipitated and electrophoresed in a 10% SDS-
olyacrylamide gel (Fig. 2B). Even though the protein
as efficiently expressed, as revealed by incorporation
f 35S, no incorporation of 32P was observed in cells
xpressing NSs-CD17. This result suggested that serine
52 and/or 256 were phosphorylated and led us to con-
FIG. 1. (A) Immunoprecipitation of NSs protein, using anti-NSs anti-
odies, from VC10 cells labeled with [35S]methionine/cysteine (lanes
–4) or [32P]orthophosphate (lanes 5–8). Cells were infected with MP12
lanes 1, 2, 5 and 6) or mock infected (lanes 3, 4, 7, and 8) and
ractionated into cytoplasmic (lanes 1, 3, 5, and 7) and nuclear extracts
lanes 2, 4, 6, and 8). (B) Immunoprecipitation of NSs protein from
P12-infected cells. The protein from 35S-methionine/cysteine-labeled
C10 cells was analyzed in a Tris–Tricine gel. Lane 1: in vitro dephos-
horylated NSs protein from total cells. Lanes 2 and 3: untreated
ytoplasmic and nuclear forms, respectively.truct and analyze NSs mutants in which the serine
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519PHOSPHORYLATION OF RIFT VALLEY FEVER VIRUS NSs PROTEINesidues 252 and/or 256 were replaced by alanine (Fig.
A).
Nuclear and cytoplasmic fractions were isolated from
V1 cells infected with vTF7–3 and transfected with
lasmids expressing NSs, NSs-Ala252, NSs-Ala256, or
Ss-Ala252/256. By Western blot analysis, carried out to
erify protein expression, we found that ;50% of the
utated or wild-type protein remained in the cytoplasm
Fig. 2C), indicating that none of these alanine substitu-
ions affected the transport of the protein or its nucleo/
ytoplasmic distribution. When cells were labeled with
32
FIG. 2. (A) Schematic representation of the carboxy-termini of the
Ss protein and various mutants. The star below methionine at posi-
ion 250 indicates the CNBr cleavage site generating the carboxy-
erminal peptide carrying serines 252 and 256. (B) Immunopreciptation
f NSs-CD17 protein using anti-NSs antibodies from CV1 cells infected
ith vTF7–3, transfected with plasmid pGem NSs-CD17, and labeled
ith [35S]methionine/cysteine (lanes 1–2) or [32P]orthophosphate (lanes
–4). Proteins from cytoplasmic (lanes 1 and 3) and nuclear extracts
lanes 2 and 4) were analyzed. (C) Western blot analysis using anti-NSs
ntibodies. Cells expressing NSs-Ala252 (lanes 1–2), NSs-Ala256
lanes 3–4), and NSs-Ala252/256 (lanes 5–6), wild-type NSs (lanes 7–8)
r mock infected (lanes 9–10) were fractionated into cytoplasmic (lanes
, 3, 5, 7, and 9) and nuclear extracts (lanes 2, 4, 6, 8, and 10). (D) NSs
rotein was immunoprecipitated with anti-NSs antibodies from cyto-
lasmic and nuclear extracts of CV1 cells infected with vTF7–3, trans-
ected with expression plasmids carrying the genes coding for NSs
rotein or its mutants, and labeled with 32P-orthophosphate. CV1 cells
xpressing wild-type NSs (lane 1) NSs-Ala252 (lane 2), NSs-Ala256
lane 3), NSs-Ala252/256 (lane 4), cells infected with vTF7–3 (lane 5) or
ninfected (lane 6).P]orthophosphate, SDS–polyacrylamide gel analysis hf the immunoprecipitated protein revealed radioactivity
ssociated with NSs-Ala252 and NSs-Ala256 (Fig. 2D).
owever, quantification in a phosphoimager (Storm, Mo-
ecular Dynamics), indicated that the 32P counts associ-
ted with mutants NSs-Ala252 or NSs-Ala256 present in
he cytoplasm or the nucleus were reduced to ;40%
hen compared to the wild-type NSs expressed similarly
n the vTF7–3-infected cells (Fig. 2D). These values were
alculated assuming that the wild-type NSs protein, and
he mutated forms were expressed at similar levels as
hown by Western blot (Fig. 2C). Moreover the mutant
Ss-Ala252/256 in which both serines 252 and 256 had
een changed to alanine retained no detectable 32P label
Fig. 2D), suggesting that both residues are the major
hosphorylation sites. It should be noted that in this
xpression system, in addition to the NSs polypeptide of
he expected molecular mass, a slightly faster migrating
olypeptide labeled with 35S and 32P was synthesized. A
imilar incomplete form of NSs, which might be due to
roteolysis or internal initiation of translation, also was
bserved during expression via the Semliki Forest virus
eplicon but not during infection with RVFV strain MP12
Yadani et al., 1999).
iochemical analysis of NSs phosphorylation
uring RVFV infection
Although these data seem to indicate that serine res-
dues 252 and 256 are phosphorylated, it cannot be
xcluded that the protein undergoes a cascade phos-
horylation, as it occurs in the P protein of VSV New
ersey serotype (Das et al., 1995a). To analyze further the
hosphorylation sites and to determine whether a cas-
ade phosphorylation occurs in the process of NSs
hosphorylation, we analyzed the 32P-labeled NSs pro-
ein isolated from the cytoplasmic and nuclear compart-
ents of RVFV-MP12-infected VC10 cells. In a first step,
hosphoamino acids were analyzed after complete acid
ydrolysis of the protein and separation of phos-
hoamino acids by electrophoresis on cellulose plates.
erine was found to be the only phosphorylated amino
cid present both in the cytoplasmic and nuclear forms
f NSs (Fig. 3A). Peptide maps then were established
sing cyanogen bromide (CNBr), a chemical that cleaves
roteins at the carboxy-terminal edge of methionine. A
heoretical analysis indicated that complete degradation
ith CNBr should generate 10 peptides, one of which
ontains both serines 252 and 256 (Fig. 2A). Figure 3B1
hows the map of the cytoplasmic NSs protein ex-
ressed in VC10 cells infected with MP12: two spots
ere detected, an intense one called A, which was more
egatively charged as it migrated closer to the positive
ole during electrophoresis, and a less intense one,
alled B, which was less hydrophilic than spot A as it
igrated faster during thin layer chromatography in theydrophobic phosphochromatography buffer. The NSs
p
s
t
B
B
A
a
s
C
a
N
p
u
t
t
n
a
p
i
t
m
e
(
t
t
p
n
m
t
t
p
f
f
p
v
s
a
a
b
N
m
s
m
r
a
M
f
c
o
4
c ar indic
520 KOHL, DI BARTOLO, AND BOULOYrotein present in the nuclear fraction was analyzed
imilarly and produced a single spot, identical in migra-
ion to spot A (Fig. 3B2).
iochemical analysis of mutant NSs proteins
To identify the peptides corresponding to spots A and
, we established the peptide maps of mutants NSs-
la252 or 256. The mutated proteins should not generate
spot migrating like A. Furthermore if spot B corre-
ponds to a monophosphorylated peptide, the map of
NBr-cleaved mutant NSs-Ala252 and 256 should reveal
spot identical in mobility to spot B. Thus the wild-type
Ss MP12 protein and the mutated forms were ex-
ressed in CV1 cells from T7-promoter driven plasmids
sing the vaccinia recombinant vTF7–3 and labeled in
he presence of [32P]orthophosphate. Labeled NSs pro-
ein from nuclear and cytoplasmic fractions was immu-
oprecipitated and further processed for CNBr cleavage
nd peptide mapping.
First, we ensured that phosphorylation of NSs ex-
ressed after transfection of plasmid pGem4Z–NSs us-
ng the vTF7–3 system was identical to the protein syn-
hesized in cells infected with MP12 strain. Indeed, the
aps of the recombinant and authentic proteins from
FIG. 3. (A) Phosphoamino acid analysis of NSs protein immunoprecip
P12. Position of origin and standards phosphoserine (P-Ser), phospho
orm; lane 2: cytoplasmic form. The star indicates the origin. (B) Two-di
leaved by CNBr. NSs protein from VC10 cells infected with MP12 (pane
r from AP61 mosquito cells infected with MP12 (panels 5–6). The pro
, and 6). Electrophoresis and chromatography in the first and second d
ompared to the others. Radioactive spots are labeled A and B; the stither the nuclear or cytoplasmic extracts were identical snot shown), indicating that viral proteins or cellular fac-
ors induced by RVFV MP12 infection, do not influence
he phosphorylated states of NSs protein.
When mutant NSs-Ala252 was expressed, the phos-
hopeptide map of the cytoplasmic (Fig. 3B3) or the
uclear form (Fig. 3B4) revealed only one spot with a
obility identical to spot B, and a peptide corresponding
o spot A was indeed no longer detected. To ascertain
hat the labeled peptide from this mutant comigrated with
eptide B generated from the NSs protein expressed
rom pGem4Z–NSs-transfected cells, the NSs proteins
rom both sources were degraded, artificially mixed, and
hosphopeptides analyzed. As expected, spot A was
isible and spot B turned out to be a single spot (not
hown), indicating that the phosphopeptides from the
uthentic NSs and the mutant comigrated. Thus spot B
ppeared to represent the monophosphorylated car-
oxy-terminal cleavage peptide. The mutated protein
Ss-Ala256 also was mapped and produced only one
onophosphorylated peptide migrating like spot B (not
hown). The absence of spot A in the maps of the
utated NSs proteins added further evidence that spot A
epresents a peptide diphosphorylated at serines 252
nd 256. Altogether, our results strongly suggest that
rom nuclear and cytoplasmic extracts of VC10 cells infected with RVFV
ine (P-Thr), and phosphotyrosine (P-Tyr) are indicated. Lane 1: nuclear
nal peptide maps of 32P-labeled NSs protein, immunoprecipitated and
, CV1 cells after transient gene expression of NSs-Ala252 (panels 3–4),
s extracted from cytoplasm (panels 1, 3, and 5) and nuclei (panels 2,
n are indicated. Panels 3 and 4 were exposed three- to fourfold longer
ates the origin.itated f
threon
mensio
ls 1–2)
tein wa
imensioerines 252 and 256 are the major phosphorylation sites
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521PHOSPHORYLATION OF RIFT VALLEY FEVER VIRUS NSs PROTEINf RVFV MP12 NSs protein in the nucleus and the cyto-
lasm. Although a monophosphorylated form of NSs
rotein was not detected in the nucleus, such a form
ight exist in nondetectable amounts.
hosphorylation of NSs protein
n AP61 mosquito cells
During infection of the mosquito cell line AP61 with the
P12 strain, the NSs protein retains its basic properties
nd forms intranuclear structures as in VC10 cells. Ex-
ression in AP61 cells is, however, delayed when com-
ared to VC10 cells as it is first detected at 18 h p. i.
ompared to 5 h p. i. in VC10 cells (unpublished data).
etabolic labeling with [32P]orthophosphate from 20 to
4 h p.i. showed that the NSs protein was labeled in the
ucleus and the cytoplasm of RVFV-MP12-infected AP61
ells. Subsequently peptide maps of NSs proteins immu-
oprecipitated from both compartments were estab-
ished. As shown in Fig. 3B (panels 5 and 6), peptides
ith similar migration patterns were generated in mam-
alian and mosquito cells, but the relative intensity of
pot A and B differed: spot B represented ;30% of the
otal counts (estimated by phosphoimager) in NSs from
osquito cells and ,5% in the protein from VC10 cells.
hese results strongly suggest that the NSs protein is
hosphorylated at the same amino acids, serines 252
nd 256, in mosquito cells and VC10 cells.
n vitro phosphorylation of NSs protein
Serines 252 and 256 of RVFV NSs MP12 protein are
ocated in consensus motifs for CKII phosphorylation. To
heck if CKII can indeed phosphorylate NSs in vitro, we
xpressed a recombinant NSs protein from plasmid pET-
Ss, which contains the NSs coding region preceded at
ts N terminus by the in-frame sequence of six histidine
esidues. Unfortunately, all attempts to produce large
mounts of recombinant NSs in E. coli failed, indepen-
ently of the strains used, and expression was detected
nly by Western blot. As an alternative, the His-tagged
rotein was synthesized in vitro in a coupled transcrip-
ion–translation reaction containing E. coli S30 extract
nd the T7 RNA polymerase (Promega). Identity of the
rotein was confirmed by Western blot using anti-NSs
ntibodies (Fig. 4A). After purification by chromatography
sing Ni-NTA–agarose beads, the recombinant NSs pro-
ein was incubated with recombinant human CKII and
-[32P]ATP. Analysis of the reaction products by electro-
horesis in a 10% SDS–polyacrylamide gel indicated
hat, alone, the bacterially expressed NSs was incapable
f autophosphorylation (Fig. 4B, lane 2) but was effi-
iently phosphorylated by recombinant CKII (Fig. 4B, lane
). Heparin is known to inhibit kinase activity of CKII (Liu
t al., 1997). Indeed, labeling of NSs was completely
nhibited when heparin was added to the reaction at a
inal concentration of 20 mg/ml (Fig. 4B, lane 4). yTo determine whether the same sites are phosphory-
ated in vitro and in vivo, a peptide map of CNBr-cleaved,
n vitro phosphorylated NSs protein was established (Fig.
C). Again, two spots migrating like A and B were de-
ected. However, in contrast with the in vivo situation,
pot B, corresponding to monophosphorylated peptide,
as more intense than A. This difference might be due to
he reaction conditions leading to incomplete phosphor-
FIG. 4. (A) Western blot analysis of expression and purification of
ecombinant NSs protein using anti-NSs antibodies. NSs protein was
xpressed from pET-NSs in an E. coli T7 S30 extract in vitro transcrip-
ion/translation system. Product from a reaction containing no plasmid
lane 1) or pET-NSs (lane 2) or purified protein (lane 3). (B) In vitro
hosphorylation of recombinant NSs protein in a reaction containing
ecombinant NSs protein and CKII in the absence (lane 1) or presence
f heparin (lane 4), NSs alone (lane 2) or recombinant CKII alone (lane
). (C) Two-dimensional peptide map of recombinant NSs protein phos-
horylated in vitro using recombinant human CKII. First (electrophore-
is) and second (chromatography) dimension are indicated. Radioac-
ive spots are marked A and B; the star indicates the origin.lation, the hindrance of one serine in the recombinant
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522 KOHL, DI BARTOLO, AND BOULOYrotein or the requirement of cellular factors (see Dis-
ussion).
DISCUSSION
In this report, we showed that the NSs protein synthe-
ized in cells infected with RVFV MP12 strain is phos-
horylated both in the cytoplasm and the nucleus and
hat serine residues at positions 252 and 256 in the
arboxy-terminus of the protein are the two major phos-
hate acceptor sites. An additional minor form, mono-
hosphorylated at either of these residues was detected
n the cytoplasm. These amino acids were localized in
avorable CKII consensus motifs (S/TXXD/E) because
cidic residues are present in the immediate vicinity of
erine/threonine at positions n11 and n12 (Kennelly
nd Krebs, 1991). Data obtained in vitro using recombi-
ant CKII strongly suggest that this kinase is involved in
he phosphorylation of NSs. As casein kinase II is ubiq-
itous in eukaryotic organisms (Li et al., 1997; Pinna,
997) and also is found in organisms closely related to
osquitoes such as Drosophila (Packman et al., 1997), it
eems likely that this kinase also phosphorylates
erines 252 and 256 in AP61 cells. Another CKII consen-
us site, which is present at threonine residue 97 in a
ess favorable sequence, does not seem to be utilized.
his was confirmed by the fact that only serine was
hosphorylated. Phosphorylation at the two serine resi-
ues is also in accordance with the analysis of the
runcated NSs protein of Clone 13 (Muller et al., 1995).
he NSs protein of this virus contains a large internal
eletion but conserves the amino- and carboxy-termini
ncluding serines 252 and 256. This truncated, rapidly
egraded protein was found to be phosphorylated and to
xhibit a similar pattern of phosphopeptides (Vialat et al.,
anuscript in preparation). Of note is that NSs of the
P12 strain contains six tyrosine residues, but tyrosine
as not found to be phosphorylated. These data differ
lightly from those obtained for the NSs protein from
nother RVFV strain, ZH 501, which revealed phospho-
erine and phosphothreonine (Parker et al., 1984). This
ifference might be strain specific.
In addition to the CKII and PKC sites, the NSs protein
f RVFV MP12 contains four consensus sites for protein
inase A, one for CaMII kinase, four for casein kinase I
nd two for glycogen synthase kinase 3 (GSK-3). Phos-
horylation of serine 256 should allow serine 252 to be
hosphorylated by GSK-3 and phosphorylation of serine
52 should allow serine 256 to be phosphorylated by
asein kinase I as predicted from the primary sequence
sing Phosphobase (Kreegipuu et al., 1999). Although
KII was shown to phosphorylate independently the
erine residues 252 and 256 in vitro and probably in vivo,
t cannot be excluded that GSK-3 and/or CKI, which
equire prephosphorylation at position 256 and 252, re-
pectively, also are implicated in vivo. AA number of proteins of segmented and nonseg-
ented negative-stranded RNA viruses has been shown
o be phosphorylated by CKII and/or PKC (De and Ban-
rjee, 1997; Sanz-Ezquerro et al., 1998). Casein kinase II
as found to phosphorylate the P protein of VSV (Das et
l., 1995a), respiratory syncytial virus (Mazumder and
arik, 1994; Villanueva et al., 1994), and measles virus
Das et al., 1995b), whereas the P proteins of human
arainfluenza virus type 3 and borna disease virus are
hosphorylated by PKC (Huntley et al., 1995; Schwemmle
t al., 1997) and the P protein of canine distemper virus
s phosphorylated by PKC and CKII (Liu et al., 1997).
espite the presence of PKC-consensus sites, the NSs
rotein of RVFV does not seem to involve the ubiquitous
KC for its phosphorylation.
Many questions concerning the phosphorylation and
unction of the NSs protein await the development of an
n vitro replication system and reverse genetics. In the
bsence of this methodology, we tested the effect of
RB, a CKII inhibitor (Critchfield et al., 1997) on the virus
ield during a one-step growth cycle in VC10 cells. Even
t the highest concentration (50 mg/ml), the drug did not
nhibit virus production measured by plaque assay. Al-
hough DRB might not completely inhibit the cellular CKII
ctivity, the absence of effect of the drug on the viral yield
eems to indicate that phosphorylation of NSs does not
lay a major role in the viral cycle. Similar conclusions
ere reported for the M protein of Sendai virus, the M2
rotein of influenza A virus (Sakaguchi et al., 1997;
homas et al., 1998) or the pre-S protein of duck hepatitis
virus (Borel et al., 1998) because viruses deficient for
hosphorylation in these proteins were able to grow in
issue culture or in animal models. In fact, phosphoryla-
ion of NSs does not seem to play an important role in the
ransport of the protein to the nucleus and the formation
f filaments: the monophosphorylated NSs-Ala 252, 256,
he unphosphorylated NSs-252/256 (Yadani et al., 1999),
r another mutant in which the two serine residues 252
nd 256 were replaced by aspartic acid (not shown)
igrate to the nucleus and form filaments. Finally, the
acterially expressed unphosphorylated NSs protein
as able to form dimers, the basic unit of filaments.
One also should consider the possibility that the NSs
rotein plays an accessory role. If so, inhibition of phos-
horylation or alteration in its phosphorylation sites will
ot affect the growth of the virus. The idea that RVFV NSs
ight have an accessory role was originally raised with
he existence of Clone 13. Interestingly, there is an in-
reasing number of viruses that are shown to possess
ccessory proteins: the human and bovine respiratory
yncytial viruses and their nonstructural NS2 protein
Buchholz et al., 1999; Teng and Collins, 1999), SV5 and
ts SH protein (He et al., 1998), Sendai virus and its V
rotein (Kato et al., 1997, Delenda et al., 1998), and
easles virus and its C protein (Escoffier et al., 1999).
lthough these were found to be nonessential for growth
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523PHOSPHORYLATION OF RIFT VALLEY FEVER VIRUS NSs PROTEINn tissue culture, the two latter play an important role
uring pathogenesis and replication in mice and human
eripheral blood cells, respectively. Because RVFV is an
rbovirus that provokes a clear cytopathic effect in mam-
alian but not in mosquito cells, it was interesting to
ompare the NSs proteins synthesized in both cell types.
owever, the same sites of phosphorylation appeared to
e utilized in both hosts. To analyze further the putative
ole of NSs phosphorylation, it would be of interest to
etermine the tissue tropism and virulence of virus defi-
ient for NSs phosphorylation.
MATERIALS AND METHODS
ells, viruses, and transfection
vc10 (VC10) and CV1 cells, which are both derived
rom African green monkey kidney, were cultured in
MEM containing, respectively, 5 and 10% fetal calf se-
um (FCS). Penicillin (200 units/ml) and streptomycin (200
g/ml) were added to the medium. VC10 cells grown in
5-mm dishes were infected with the attenuated RVFV
train MP12 (Caplen et al., 1985), at a m.o.i. of 5 pfu per
ell. For transient gene expression based on T7-pro-
oter-driven plasmids, CV1 cells grown in 35-mm dishes
ere infected with the vaccinia recombinant expressing
7 RNA polymerase vTF7–3 (Fuerst et al., 1986; kindly
rovided by B. Moss) at a m.o.i. of 5 pfu per cell and
ransfected with 5 mg of plasmid DNA using DAC-30
Eurogentec, Belgium) as transfecting agent.
lasmids
Plasmids carrying the NSs gene of RVFV MP12 and
he mutated forms were already described (Yadani et al.,
999). The prokaryotic expression vector pET-NSs as
ell as pGem-NSsCD17 were kindly provided by F.
adani.
adiolabeling, immunoprecipitation, and Western
lotting
RVFV-infected VC10 cells were starved at 5 h p. i. for
h in phosphate-free DMEM (ICN, Costa Mesa, CA), and
abeled for 2 h in the presence of 500 mCi/0,5 ml of
32P]orthophosphate (ICN, Costa Mesa, CA) and 2% FCS.
TF7–3-infected/transfected CV1 cells were starved at
8 h p. i. for 1 h in phosphate-free DMEM and labeled
uring 3 h in the presence of 500 mCi [32P]orthophos-
hate per 0,5 ml and 2% FCS. RVFV-infected VC10 cells
r vTF7–3-infected/transfected CV1 cells were starved at
or 18 h p. i., respectively, for 1 h in methionine- and
ysteine-free DMEM and labeled for 2 h with 100 mCi/ml
f a mixture of [35S]methionine and [35S]cysteine (Promix,
mersham).
Nuclear and cytoplasmic extracts were prepared ac-
ording to the procedure described by Avalos et al.
1997). Production of antibodies against NSs and immu- roprecipitation of nuclear and cytoplasmic extracts
which were diluted 20-fold in solubilization buffer) have
lready been described (Yadani et al., 1999). For Western
lot, proteins separated by electrophoresis in 10% SDS-
olyacrylamide gel were transferred onto a nylon mem-
rane. After incubation for 60 min in buffer containing 5%
ow-fat milk, mouse antibodies against the NSs protein
ere added at a 1:500 dilution and incubated overnight
t 4°C. Complexes were revealed with peroxidase-la-
eled anti-mouse IgG using Supersignal (Pierce, Rock-
ord, IL) as a substrate.
AP61 cells were cultured at 28°C in L-15 medium
ontaining 10% fetal calf serum (FCS), tryptose phos-
hate broth, penicillin (200 U/ml), and streptomycin (200
g/ml). For labeling studies, 2 3106 AP61 were incu-
ated in phosphate-free L-15 medium (Specialty
edia, Phillipsburg, NJ) containing 0,5 mCi/0,5 ml
32P]orthophosphate and 2% FCS for 4 h from 20 to 24 h
. i.
ris–Tricine gels
Tris–Tricine SDS polyacrylamide gels (10%T, 3%C; %T,
otal monomer concentration, %C, weight percentage of
rosslinker) were prepared as described (Scha¨gger and
on Jagow, 1987) and run in a Protean II xi cell (Bio-Rad
aboratories, Hercules, CA). Separating gels were 11 cm
ong. Protein dephosphorylation using alkaline phospha-
ase was performed as described (Pre´haud et al., 1990)
hosphoamino acid analysis
Phosphoamino acid analysis was performed using the
rotocol described by Ley et al. (1991). Briefly, 32P-labeled
Ss was immunoprecipitated, separated in a 10% SDS–
olyacrylamide gel, and transferred onto a PVDF mem-
rane (Immobilon P, Millipore). Blots were autoradio-
raphed to determine the position of radiolabeled NSs
rotein. Bound protein was hydrolyzed in 6 M HCl for 1 h
t 110°C. The hydrolysate was dried under vacuum,
issolved in 0.1 M acetic acid containing a mixture of
tandards phosphothreonine, phosphoserine, and phos-
hotyrosine, and separated by electrophoresis on a thin-
ayer cellulose plate (Merck, Darmstadt, Germany). The
late was autoradiographed at 270°C and standard
hosphoamino acids were stained with ninhydrin.
yanogen bromide cleavage and phosphopeptide
apping
32P-labeled NSs protein was immunoprecipitated, sep-
rated in 10% SDS–polyacrylamide gel and transferred
nto a Hybond C-pure nitrocellulose membrane (Amer-
ham, Les Ulis, France). Blots were autoradiographed to
etermine the position of radiolabeled NSs protein. Cy-
nogen bromide (CNBr) cleavage was performed as de-
cribed by Luo and Sefton (1990), and samples were
esuspended in TLE buffer (pH 1.9). Two-dimensional
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524 KOHL, DI BARTOLO, AND BOULOYeparation on thin-layer cellulose plates was carried out
s described by Boyle et al. (1991). Briefly, samples were
potted on cellulose TLC plates and resolved by electro-
horesis (1000 V, 100 mA, 30 min) in TLE buffer (pH 1.9)
n the first dimension and by ascending TLC in phospho-
hromatography buffer for 8–10 h in the second dimen-
ion. Dried plates were autoradiographed at 270°C.
urification of recombinant NSs protein
NSs protein was expressed from pET-NSs (a kind gift
f F. Yadani), using the E. coli T7 S30 extract system for
n vitro transcription/translation of circular DNA (Pro-
ega, Lyon, France) according to the manufacturer’s
rotocol. Plasmid pET-NSs contains an N-terminal 6-His-
agged copy of the NSs gene of RVFV MP12 under the
ontrol of the T7 promoter.
NSs protein was purified under native conditions us-
ng Nickel-NTA-agarose beads (Quiagen, Hilden, Ger-
any) and the buffers recommended by the manufac-
urer. Briefly, 100 ml of the reaction mix was diluted
ivefold with 13 lysis buffer (50 mM NaH2PO4 pH 8; 300
M NaCl; 10 mM imidazole), and 25 ml of Nickel-NTA-
garose beads and 2.5 ml of 100 mM PMSF solution
ere added. The mix was incubated for 18 h at 4°C
nder constant, mild shaking. Beads were centrifuged
13,500 rpm, 4°C) and washed twice, and NSs protein
luted three times in 20 ml elution buffer. Eluates were
ooled. The purified protein was dialyzed against a
uffer containing 50 mM Tris–HCl (pH 7.5), 10 mM MgCl2,
nd 100 mM NaCl.
n vitro phosphorylation
Reaction conditions for in vitro phosphorylation using
ecombinant human CKII (Boehringer Mannheim, Ger-
any) and g-[32P]ATP have been described previously
Liu et al., 1997). Reactions containing 0.5 mg NSs protein
nd 0.01 mU of recombinant CKII in a total volume of 20
l were incubated for 1 h at 30°C, precipitated with 4
olumes of acetone and washed in the presence of 1 mM
old ATP solution to remove excess g-[32P]ATP. Samples
hen were analyzed in a 10% SDS–polyacrylamide gel
nd autoradiographed.
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